Management of kidney cancer in Asia: Resource-stratified guidelines from the Asian Oncology Summit 2012

Edmund Chiong, Miah Hiang Tay, Min Han Tan, Santosh Kumar, Hong Gee Sim, Bin Tean Teh, H. Rainy Umbas, Noan Minh Chau

Research output: Contribution to journalReview articlepeer-review

26 Citations (Scopus)

Abstract

Treatment of renal-cell carcinoma has progressed over the past decade, in terms of surgical and systemic therapy. Current treatment guidelines are based on clinical evidence, but do not take into account resource limitations among different countries. These limitations, which include financial and logistical challenges and lack of skilled health-care professionals, have the greatest effect in low-income countries. This consolidated statement gives treatment recommendations for renal-cell carcinoma that are based on clinical evidence and stratified according to extent of resource availability. The statement was formulated by a panel of urologists, medical oncologists, and clinical oncologists from Asian countries, at a consensus session on kidney cancer that was held as part of the 2012 Asian Oncology Summit in Singapore. Resource levels are defined according to a four-tier system (basic, limited, enhanced, and maximum), and treatment recommendations are specified based on availability of financial, skill, and logistical resources.

Original languageEnglish
Pages (from-to)e482-e491
JournalThe Lancet Oncology
Volume13
Issue number11
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Dive into the research topics of 'Management of kidney cancer in Asia: Resource-stratified guidelines from the Asian Oncology Summit 2012'. Together they form a unique fingerprint.

Cite this